EMIT Imaging

Cryo-Fluorescence Tomography (CFT) is a novel, 3D approach to imaging drug distribution and protein expression in whole animals and large tissue samples. EMIT Imaging offers both instrumentation and services via our imaging platform, XerraTM, a high-resolution, high-sensitivity preclinical imaging tool designed to advance discoveries in biological and drug research. See what youre missing with standard 2D in vivo fluorescence imaging techniques and utilize CFT to better visualize: - Whole-body drug distribution and delivery - Screening candidate drugs and delivery systems - Whole-body therapeutic protein expression - Multiplexed co-localization of drug with targets - On and off target tissue identification

Molecular tissue imaging,cryo-fluorescence tomography,mesoscopic,automated tissue imaging,gene therapy,oncology,drug discovery,research,cell therapy,immunotherapy,drug development,fluorescence,drug delivery,pk/pd,preclinical imaging,xerra,and cft services

Emit imaging operates in the Biotechnology research industry.

Emit imaging's revenue is 11m - 100m

Emit imaging has 11 - 50 employees.